# Organic Dust Exposure Enhances SARS-CoV-2 Entry in a PKCα- and ADAM-17-Dependent Manner

**Authors:** Abenaya Muralidharan, Christopher D. Bauer, Claire G. Nissen, St Patrick Reid, Jill A. Poole, Todd A. Wyatt

PMC · DOI: 10.3390/ijtm4030032 · 2025-03-28

## TL;DR

Exposure to organic dust increases SARS-CoV-2 entry into cells through PKCα and ADAM-17, worsening infection risk in agricultural workers.

## Contribution

The study reveals a novel mechanism by which organic dust exposure enhances SARS-CoV-2 infection via ACE2 modulation.

## Key findings

- ODE increases ACE2 shedding in mice via ADAM-17, correlating with higher pseudovirus titer.
- PKCα activity in human cells influences ACE2 expression and pseudoviral entry.
- IL-8 secretion after infection is reduced independently of PKCα and ADAM-17.

## Abstract

SARS-CoV-2, the causative agent of the COVID-19 pandemic, has had a global impact, affecting millions over the last three years. Pre-existing lung diseases adversely affect the prognosis of infected COVID-19 patients, and agricultural workers routinely exposed to inhalable organic dusts have substantial increased risk for developing chronic lung diseases. In previous studies, we characterized the protein kinase C (PKC)-dependent airway inflammation mediated by organic dust extract (ODE) derived from dust collected from swine confinement facilities in in vitro and in vivo models. Here, we studied the effect of ODE on SARS-CoV-2 pseudoviral infection in mice and human bronchial epithelial cells (BEAS-2B). In wild-type (WT) and transgenic mice expressing the human angiotensin I-converting enzyme 2 (ACE2) receptor (SARS-CoV-2 entry receptor), ODE increased ACE2 shedding by ADAM-17 in the lungs. After repeated ODE treatments, the increased soluble ACE2 correlated to higher pseudovirus titer in the mouse lungs. In the human bronchial epithelial cells, ODE augmented PKCα activity in WT cells, and membrane ACE2 expression was diminished in PKCα-dominant negative cells. Unlike in the mice, increasing membrane ACE2 levels by treating with PKCα or ADAM-17 inhibitors and a low dose of ODE enhanced pseudoviral entry in vitro. Following viral entry, IL-8 secretion by the cells was diminished in a PKCα- and ADAM- 17-independent manner. Together, the complex mechanisms involved in the synergistic effects of agricultural dust and SARS-CoV-2 highlight the importance of studying dust-mediated changes to immunity against circulating pathogens.

## Linked entities

- **Genes:** ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272], PRKCA (protein kinase C alpha) [NCBI Gene 5578], ADAM17 (ADAM metallopeptidase domain 17) [NCBI Gene 6868]
- **Proteins:** ACE2 (angiotensin converting enzyme 2), PRKCA (protein kinase C alpha), ADAM17 (ADAM metallopeptidase domain 17), CXCL8 (C-X-C motif chemokine ligand 8)
- **Diseases:** COVID-19 (MONDO:0100096)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** PRKCA (protein kinase C alpha) [NCBI Gene 5578] {aka AAG6, PKC-alpha, PKCA, PKCI+/-, PKCalpha}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, ADAM17 (ADAM metallopeptidase domain 17) [NCBI Gene 6868] {aka ADAM18, CD156B, CSVP, HYPT16, NISBD, NISBD1}
- **Diseases:** infected (MESH:D007239), lung diseases (MESH:D008171), airway inflammation (MESH:D007249), COVID-19 (MESH:D000086382)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Sus scrofa (pig, species) [taxon 9823], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]
- **Cell lines:** BEAS-2B — Homo sapiens (Human), Transformed cell line (CVCL_0168)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11951273/full.md

---
Source: https://tomesphere.com/paper/PMC11951273